BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33262464)

  • 1. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
    Bala P; Singh AK; Kavadipula P; Kotapalli V; Sabarinathan R; Bashyam MD
    Oncogene; 2021 Jan; 40(4):863-874. PubMed ID: 33262464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    Kumar R; Raman R; Kotapalli V; Gowrishankar S; Pyne S; Pollack JR; Bashyam MD
    J Mol Med (Berl); 2018 Feb; 96(2):135-146. PubMed ID: 29124284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications.
    Shukla P; Dange P; Mohanty BS; Gadewal N; Chaudhari P; Sarin R
    Cancer Gene Ther; 2022 Dec; 29(12):1908-1917. PubMed ID: 35869277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
    Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
    Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
    Akinjiyan FA; Nassief G; Phillipps J; Adeyelu T; Elliott A; Abdulla F; Zhou AY; Souroullas G; Kim KB; Vanderwalde A; Park SJ; Ansstas G
    Sci Rep; 2024 Feb; 14(1):3444. PubMed ID: 38341515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic
    Walter DM; Venancio OS; Buza EL; Tobias JW; Deshpande C; Gudiel AA; Kim-Kiselak C; Cicchini M; Yates TJ; Feldser DM
    Cancer Res; 2017 Apr; 77(7):1719-1729. PubMed ID: 28202515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
    Kim JE; Choi J; Sung CO; Hong YS; Kim SY; Lee H; Kim TW; Kim JI
    Exp Mol Med; 2021 Mar; 53(3):446-456. PubMed ID: 33753878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
    Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
    Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.
    Lee SH; Jung SH; Kim TM; Rhee JK; Park HC; Kim MS; Kim SS; An CH; Lee SH; Chung YJ
    Oncotarget; 2017 Jan; 8(4):6579-6588. PubMed ID: 28179590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy.
    Yang J; Lin Y; Huang Y; Jin J; Zou S; Zhang X; Li H; Feng T; Chen J; Zuo Z; Zheng J; Li Y; Gao G; Wu C; Tan W; Lin D
    Theranostics; 2019; 9(23):6856-6866. PubMed ID: 31660073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
    Shain AH; Pollack JR
    PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
    Laskar RS; Ghosh SK; Talukdar FR
    Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers.
    Ye W; Ling S; Liu RY; Pan ZZ; Wang G; Gao S; Wu J; Cao L; Dong L; Li Y; Zhou Y; Du W; Meng X; Chen J; Guan X; He Y; Pan C; Zheng XS; Lu X; Chen S; Huang W
    J Pathol; 2018 Jun; 245(2):222-234. PubMed ID: 29537081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
    Libera L; Craparotta I; Sahnane N; Chiaravalli AM; Mannarino L; Cerutti R; Riva C; Marchini S; Furlan D
    Hum Pathol; 2018 Nov; 81():235-244. PubMed ID: 30420047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Chakrabarty S; Varghese VK; Sahu P; Jayaram P; Shivakumar BM; Pai CG; Satyamoorthy K
    Br J Cancer; 2017 Jun; 117(1):136-143. PubMed ID: 28524162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.